Together we will beat cancer

Donate
Harry Jenkins

Harry studied an integrated Master’s degree in biology at Durham University before joining Cancer Research UK in November 2018. He recently completed a Master’s in science communication at Imperial College London part-time alongside his work in communications teams across the charity. He currently sits in Cancer Research UK’s digital news team, writing news and analysis articles for their news site as well as information about their funded research for their website.

Childhood cancer survivors at greater risk of ill health

People who survive cancer in childhood have a higher risk of ill health as they grow older, according to new research published in The Lancet Regional Health – Europe.

Read More

Three cancer drugs approved for NHS use in Scotland

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

Read More

Unravelling the mystery of Barrett’s oesophagus

Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now.

Read More

Cancer in children and young people: how far we’ve come

Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children’s and young people’s cancers.

Read More

The Galleri multi-cancer blood test: What you need to know

There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test.

Read More

Improving cancer care for the LGBTQ+ community

LGBTQ+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQ+ people.

Read More

Blood test could tailor treatment after surgery

A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.

Read More

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

Read More

Common anti-inflammatory drug could boost cancer immunotherapy

Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.

Read More

Pancreatic cancer cells use the same energy as sprinters’ muscles to spread

Our scientists are using hydrogels to understand more about how pancreatic cancer cells spread.

Read More